Short-term prognosis, mid- and long-term clinical follow-up of bronchoscopic intervention therapy combined with bronchial artery embolization on massive hemoptysis
BackgroundTo explore the short-term prognosis, mid- and long-term clinical follow-up of bronchoscopic intervention therapy (BIT) combined with bronchial artery embolization (BAE) in the treatment of massive hemoptysis.MethodsPatients with massive hemoptysis who received BAE (BAE group) or BAE combin...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Surgery |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fsurg.2025.1642449/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849240751814213632 |
|---|---|
| author | Kunying Li Taomei Lian Zhenjing Wang Zhengxun Zhang Wenbo Wang Jiaping Qian |
| author_facet | Kunying Li Taomei Lian Zhenjing Wang Zhengxun Zhang Wenbo Wang Jiaping Qian |
| author_sort | Kunying Li |
| collection | DOAJ |
| description | BackgroundTo explore the short-term prognosis, mid- and long-term clinical follow-up of bronchoscopic intervention therapy (BIT) combined with bronchial artery embolization (BAE) in the treatment of massive hemoptysis.MethodsPatients with massive hemoptysis who received BAE (BAE group) or BAE combined with BIT (BAE & BIT group) based on standard clinical treatment were included retrospectively, during June 2022 and March 2023. The short-term prognosis assessed by the therapeutic response, hemoptysis recurrence rates at 1-month post-surgery, and postoperative complications were compared. Mid- and long-term clinical follow-up data were collected.ResultsData were collected from 136 patients. There were 68 patients (aged 21–60 years, 31 males) received BAE & BIT, and 68 patients (aged 20–59 years, 36 males) received BAE were matched. After surgery, the immediate response rate and total response rate in BIT & BAE group were significantly higher than those in BAE group, while comparable hemoptysis recurrence rates at 1-month post-surgery. Patients in BIT & BAE group had significantly lower rates of postoperative complications, including obstructive pneumonia lung consolidation, and atelectasis, compared to those in BAEgroup. No death in the BIT & BAE group, while the BAE group experienced 3 intraoperative deaths and 4 cases requiring conversion to surgical intervention. No recurrence was observed during the mid-term and long-term follow-up.ConclusionCompared to BAE alone, BIT combined with BAT may offer better short-term prognosis, including higher response rate, lower rates of postoperative complications and mortality, in the management of massive hemoptysis, with a good mid- and long-term therapeutic effects. |
| format | Article |
| id | doaj-art-b0cc255b709f46fdab03612613c355aa |
| institution | Kabale University |
| issn | 2296-875X |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Surgery |
| spelling | doaj-art-b0cc255b709f46fdab03612613c355aa2025-08-20T04:00:27ZengFrontiers Media S.A.Frontiers in Surgery2296-875X2025-08-011210.3389/fsurg.2025.16424491642449Short-term prognosis, mid- and long-term clinical follow-up of bronchoscopic intervention therapy combined with bronchial artery embolization on massive hemoptysisKunying Li0Taomei Lian1Zhenjing Wang2Zhengxun Zhang3Wenbo Wang4Jiaping Qian5Department of Endoscopy, Henan Provincial Chest Hospital, Zhengzhou, Henan, ChinaFirst Department of Tuberculosis, Henan Provincial Chest Hospital, Zhengzhou, Henan, ChinaDepartment of Endoscopy, Henan Provincial Chest Hospital, Zhengzhou, Henan, ChinaFifth Department of Cardiology, Henan Provincial Chest Hospital, Zhengzhou, Henan, ChinaThird Department of Thoracic Surgery, Henan Provincial Chest Hospital, Zhengzhou, Henan, ChinaDepartment of Endoscopy, Henan Provincial Chest Hospital, Zhengzhou, Henan, ChinaBackgroundTo explore the short-term prognosis, mid- and long-term clinical follow-up of bronchoscopic intervention therapy (BIT) combined with bronchial artery embolization (BAE) in the treatment of massive hemoptysis.MethodsPatients with massive hemoptysis who received BAE (BAE group) or BAE combined with BIT (BAE & BIT group) based on standard clinical treatment were included retrospectively, during June 2022 and March 2023. The short-term prognosis assessed by the therapeutic response, hemoptysis recurrence rates at 1-month post-surgery, and postoperative complications were compared. Mid- and long-term clinical follow-up data were collected.ResultsData were collected from 136 patients. There were 68 patients (aged 21–60 years, 31 males) received BAE & BIT, and 68 patients (aged 20–59 years, 36 males) received BAE were matched. After surgery, the immediate response rate and total response rate in BIT & BAE group were significantly higher than those in BAE group, while comparable hemoptysis recurrence rates at 1-month post-surgery. Patients in BIT & BAE group had significantly lower rates of postoperative complications, including obstructive pneumonia lung consolidation, and atelectasis, compared to those in BAEgroup. No death in the BIT & BAE group, while the BAE group experienced 3 intraoperative deaths and 4 cases requiring conversion to surgical intervention. No recurrence was observed during the mid-term and long-term follow-up.ConclusionCompared to BAE alone, BIT combined with BAT may offer better short-term prognosis, including higher response rate, lower rates of postoperative complications and mortality, in the management of massive hemoptysis, with a good mid- and long-term therapeutic effects.https://www.frontiersin.org/articles/10.3389/fsurg.2025.1642449/fulltherapeutic responsemassive hemoptysispostoperative complicationsbronchoscopic intervention therapybronchial artery embolization |
| spellingShingle | Kunying Li Taomei Lian Zhenjing Wang Zhengxun Zhang Wenbo Wang Jiaping Qian Short-term prognosis, mid- and long-term clinical follow-up of bronchoscopic intervention therapy combined with bronchial artery embolization on massive hemoptysis Frontiers in Surgery therapeutic response massive hemoptysis postoperative complications bronchoscopic intervention therapy bronchial artery embolization |
| title | Short-term prognosis, mid- and long-term clinical follow-up of bronchoscopic intervention therapy combined with bronchial artery embolization on massive hemoptysis |
| title_full | Short-term prognosis, mid- and long-term clinical follow-up of bronchoscopic intervention therapy combined with bronchial artery embolization on massive hemoptysis |
| title_fullStr | Short-term prognosis, mid- and long-term clinical follow-up of bronchoscopic intervention therapy combined with bronchial artery embolization on massive hemoptysis |
| title_full_unstemmed | Short-term prognosis, mid- and long-term clinical follow-up of bronchoscopic intervention therapy combined with bronchial artery embolization on massive hemoptysis |
| title_short | Short-term prognosis, mid- and long-term clinical follow-up of bronchoscopic intervention therapy combined with bronchial artery embolization on massive hemoptysis |
| title_sort | short term prognosis mid and long term clinical follow up of bronchoscopic intervention therapy combined with bronchial artery embolization on massive hemoptysis |
| topic | therapeutic response massive hemoptysis postoperative complications bronchoscopic intervention therapy bronchial artery embolization |
| url | https://www.frontiersin.org/articles/10.3389/fsurg.2025.1642449/full |
| work_keys_str_mv | AT kunyingli shorttermprognosismidandlongtermclinicalfollowupofbronchoscopicinterventiontherapycombinedwithbronchialarteryembolizationonmassivehemoptysis AT taomeilian shorttermprognosismidandlongtermclinicalfollowupofbronchoscopicinterventiontherapycombinedwithbronchialarteryembolizationonmassivehemoptysis AT zhenjingwang shorttermprognosismidandlongtermclinicalfollowupofbronchoscopicinterventiontherapycombinedwithbronchialarteryembolizationonmassivehemoptysis AT zhengxunzhang shorttermprognosismidandlongtermclinicalfollowupofbronchoscopicinterventiontherapycombinedwithbronchialarteryembolizationonmassivehemoptysis AT wenbowang shorttermprognosismidandlongtermclinicalfollowupofbronchoscopicinterventiontherapycombinedwithbronchialarteryembolizationonmassivehemoptysis AT jiapingqian shorttermprognosismidandlongtermclinicalfollowupofbronchoscopicinterventiontherapycombinedwithbronchialarteryembolizationonmassivehemoptysis |